Key result
Genetic screening identified pathogenic variants in BSCL2, HSPB1, and MYH7 in three families with suspected distal hereditary motor neuropathy, expanding known clinical phenotypes.
Why the study?
The study was conducted to identify the molecular defect underlying disease in three families suspected of distal hereditary motor neuropathy.
Case Report
Whole exome sequencing can identify novel or expanded clinical phenotypes, such as cardiac abnormalities in patients with MYH7 variants initially presenting with distal muscle involvement.
May aid molecular diagnosis in familial distal HMN; leaves open broader variant spectrum in larger cohorts.
Three families suspected of distal hereditary motor neuropathy underwent genetic screening with the aim to identify the molecular defect underlying the disease. The description of the identification reflects the shift in molecular diagnostics that was made during the last decades. Our candidate gene approach yielded a known pathogenic variant in BSCL2 (p.Asn88Ser) in one family, and via a CMT-capture, in HSPB1 (p.Arg127Trp), in addition to five other variations in Charcot-Marie-Tooth-related genes in the proband of the second family. In the third family, using whole exome sequencing, followed by linkage-by-location, a three base pair deletion in exon 33 of MYH7 (p.Glu1508del) was found, a reported pathogenic allele albeit for a myopathy. After identification of the causative molecular defect, cardiac examination was performed for patients of the third family and this demonstrated abnormalities in three out of five affected family members. Heterogeneity and expansion of clinical phenotypes beyond known characteristics requires a wider set of genes to be screened. Whole exome/genome analysis with limited prior clinical information may therefore be used to precede a detailed clinical evaluation in cases of large families, preventing screening of a too narrow set of genes, and enabling the identification of novel disease-associated genes. In our cases, the variants had been reported, and co-segregation analysis confirmed the molecular diagnosis.
No takes yet. Share an insight, caveat, or question.
Weterman et al. (2022) conducted a case report in Distal hereditary motor neuropathy. Genetic screening was evaluated on Identification of the molecular defect underlying the disease. Genetic screening identified pathogenic variants in BSCL2, HSPB1, and MYH7 in three families with suspected distal hereditary motor neuropathy, expanding known clinical phenotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: